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Discovering novel genes involved in immune evasion and drug resistance in the human malaria parasite, Plasmodium
falciparum, is of critical importance to global health. Such knowledge may assist in the development of new effective
vaccines and in the appropriate use of antimalarial drugs. By performing a full-genome scan of allelic variability in 14
field and laboratory strains of P. falciparum, we comprehensively identified ’500 genes evolving at higher than
neutral rates. The majority of the most variable genes have paralogs within the P. falciparum genome and may be
subject to a different evolutionary clock than those without. The group of 211 variable genes without paralogs
contains most known immunogens and a few drug targets, consistent with the idea that the human immune system
and drug use is driving parasite evolution. We also reveal gene-amplification events including one surrounding
pfmdr1, the P. falciparum multidrug-resistance gene, and a previously uncharacterized amplification centered around
the P. falciparum GTP cyclohydrolase gene, the first enzyme in the folate biosynthesis pathway. Although GTP
cyclohydrolase is not the known target of any current drugs, downstream members of the pathway are targeted by
several widely used antimalarials. We speculate that an amplification of the GTP cyclohydrolase enzyme in the folate
biosynthesis pathway may increase flux through this pathway and facilitate parasite resistance to antifolate drugs.
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Introduction
Malaria is a signiﬁcant burden on world health. The most
severe form of human malaria is caused by the apicomplexan
parasite Plasmodium falciparum. Genetic variation in this
parasite is central to the pathogenesis of the organism, as
allelic variability in different clones is thought to facilitate
immune evasion [1]. This in turn has signiﬁcantly impeded
progress towards the development of an effective malaria
vaccine [2]. Thus understanding the extent and basis of
genetic variation is important for strategies of disease
control. In addition, the study of genetic variation in
different populations and clones that differ in susceptibility
to drugs can reveal genes or genetic regions involved in drug
resistance [3], and can thus facilitate the use of more
appropriate therapies against P. falciparum and can save lives.
Despite a tradition of studying microsatellite-length poly-
morphisms in P. falciparum [4–7], many now feel that the most
efﬁcient way to study natural variation and population
structure is by shotgun sequencing, single-nucleotide poly-
morphism (SNP) discovery [8], and genotyping using arrays or
a variety of other high-throughput, low-cost approaches that
are used in human genetics. These processes all have some
limitations. First, sequencing is time-consuming, and even
though the cost is falling, shotgun sequencing faces sampling
issues and is ill suited to the task of ﬁnding genome
duplications, deletions, and ampliﬁcations, some of which
may have profound roles in drug resistance. While polony
sequencing [9] or new methodologies [10] may eventually
allow the genome of a malaria parasite to be fully sequenced
in one day, at a reasonable cost, such sequencing methods are
not yet in widespread use, and library construction generally
remains a bottleneck in the production of sequence data.
Furthermore, P. falciparum-genome intergenic regions are up
to 90% AT rich and are known to recombine when cloned in
other organisms; they created special challenges in the
original sequencing of the genome [11]. Thus it is possible
that the same low-cost approaches that can be applied to
other microbial genomes may not work as well for P.
falciparum. High-throughput genotyping of a subset of SNP
markers discovered through the sequencing of laboratory
strains is more efﬁcient than sequencing a whole genome.
However, this relies on the assumption that traits such as
drug resistance will be transmitted throughout a population
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emergence of novel alleles and haplotypes via mitotic
recombination and mutation, which may occur in P.
falciparum.
Allelic-variation scanning [12], which is a hybridization-
based method for discovering and tracking natural variation,
has the advantage that no libraries are required, sampling is
consistent and is based on an array template, no primers need
to be designed, and tens of thousands of genetic markers can
be both discovered and typed in as little as one day in any
parasite isolate, potentially using only a few milliliters of
infected patient blood as starting material. While the nature
of this technique dictates that all observed variation will be
relative to the sequenced strain represented on the array,
reproducibility is high and the method can be used for
genotyping and mapping traits in genetic crosses or through
the analysis of linkage disequilibrium and, as with full-
genome sequencing, the discovery of genes under selection
[13]. Most importantly, the method easily discovers genome-
ampliﬁcation events, which generally may not be readily
revealed by even laborious full-genome sequencing. The
simplicity of this approach could allow full-genome longi-
tudinal studies of parasite variability to be performed on
large numbers of samples in response to the introduction of a
new drug or vaccine.
Here, we systematically sample genetic variation in the
malaria parasite by analyzing the patterns that are derived
from hybridizing genomic DNA to an oligonucleotide array
covering approximately 50% of the coding regions of the P.
falciparum genome [14]. We demonstrate a highly nonrandom
distribution of variability in terms of functional classes of
genes, and we reveal genes that appear to be under increased
selection pressure from the host immune system. Under-
standing patterns of global natural variation in malaria
parasites can also assist in the functional characterization of
the genes encoded by the parasite’s genome. Applying a ‘‘guilt
by association’’ principle, we hypothesize that those highly
variable, uncharacterized genes that show similar proﬁles of
host selection, expression pattern, and localization to
validated immunogens might make promising additional
vaccine candidates for further investigation. We also report
ampliﬁcation events in a multidrug-resistance gene and
describe a previously uncharacterized ampliﬁcation in the
GTP cyclohydrolase, the ﬁrst enzyme in the frequently
targeted folate biosynthesis pathway.
Results
To investigate genome-wide diversity in the human malaria
parasite in an unbiased, comparative fashion, genomic DNA
from 14 different cloned P. falciparum lines, obtained from
four different continents (Table 1), were labeled and
hybridized in triplicate to a custom high-density oligonucleo-
tide array [14] speciﬁcally designed for studying diversity in P.
falciparum (see Materials and Methods, Table S1).
A single base change between a 25-mer microarray feature
and its genomic target results in a reproducible loss of
hybridization signal [12]. As the 25-mer probes used in this
study were designed to map to unique locations in the
genome, this approach enabled us to identify those genes that
carry nucleotide mutations relative to the sequenced strain,
3D7. These single-feature polymorphisms (SFPs) are detected
using an F-test on probe intensity values for three hybrid-
izations for the query strain and the reference strain (3D7).
Some of these SFPs correspond to SNPs which result in a
change in protein structure, some to silent SNPs [15] and, in a
few cases, these SFPs are the result of small insertion/deletion
events (‘‘indels’’), which are more frequently observed in the
non-coding regions [16], or in full deletions. We further
required that the signal intensity for the 3D7 DNA be higher
than that of the alternate strain since the physical location of
gene duplications is unknown. To overcome any issues of
variation acquired through long-term in vitro culture of
laboratory strains, ﬁve of the 14 strains analyzed were isolated
recently from Pikine, Senegal. These single clones, as
indicated by genetic typing of the merozoite surface protein
(MSP) 1 gene (unpublished data), were maintained in in vitro
culture for only a short period.
Our analysis resulted in the identiﬁcation of 23,653 SFPs
across all strains for the 298,782 25-mer P. falciparum probes
for the 23-Mb genome (Tables S2 and S3). The seven
laboratory-derived strains displayed moderately higher num-
bers of polymorphic probes (Table S4) compared to the
strains isolated from Senegal. However, the laboratory strain
D6 (originally isolated from Sierra Leone) showed consid-
erably fewer polymorphisms in comparison to all other
strains analyzed.
We had previously validated this method using a small
Chromosome 2 microarray [17], and direct nucleotide
sequencing of several alleles identiﬁed in this current study
conﬁrmed our accuracy with a low false-positive rate of ,5%
(Table 2). We also showed that these SFPs corresponded to
heritable changes at speciﬁc chromosomal loci by examining
their segregation patterns in a haploid progeny strain (C188)
which was derived from a previous cross between a
chloroquine-sensitive clone (HB3) and a chloroquine-resist-
ant clone (Dd2) [18]. We identiﬁed recombination break-
points that clearly corresponded to those previously
published (Figure 1) [19], and the analysis of co-inheritance
further conﬁrmed a false-positive rate of less than 5%,
although this number is likely to be inﬂated by the presumed
existence of genuine mitotic gene-conversion events. As more
genetic crosses between Plasmodium species become available,
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Synopsis
Variability in the genome of the human malaria parasite, Plasmo-
dium falciparum, is key to the parasite’s ability to cause disease and
overcome therapeutic interventions such as drugs and vaccines.
Elucidating the extent of genetic variation in the malaria parasite will
therefore be central to decreasing the malaria disease burden. The
authors performed a full-genome scan of variability in different
strains of P. falciparum and observed a nonrandom distribution of
variation. In particular, those genes that are predicted to have roles
in evading the host immune response or antimalarial drugs show
significantly higher levels of variation. In addition, the authors
speculate that a previously unreported genome amplification in the
folate biosynthesis pathway correlates with resistance to the
antimalarial drug sulfadoxine. Such data enable hypotheses to be
made about the function of many of the unknown elements in the
parasite’s genome, which may permit the identification of new
targets that can be investigated for incorporation into a malaria
vaccine and may aid in the understanding of how the parasite
withstands drug pressure.the rapid and reliable genotyping approach presented here
will be an important tool for the mapping of multiple
heritable traits, particularly in rodent malaria parasites [20],
either individually or through bulk segregant analysis [21].
It has been proposed that the analysis of linkage
disequilibrium may permit the discovery of loci associated
with drug resistance [4,5]. Previous linkage-disequilibrium
analysis of 342 polymorphic microsatellite markers has shown
that the mutations in the P. falciparum chloroquine-resistance
transporter gene (pfcrt) (MAL7P1.27), which give rise to
chloroquine resistance, have arisen on only four independent
occasions and that these mutations have spread across the
globe through selective sweeps [5]. We also observe that the
SFP-derived haplotypes obtained from 4,369 SFPs distin-
guishing the chloroquine-resistant strains, FCB and Dd2,
were nearly identical in the central region of Chromosome 7
and that this region (with the exception of the PfEMP1
cluster) surrounds the pfcrt gene (Figure 2). This region is the
only region that showed extensive disequilibrium and is
accompanied by impressive probability scores. For example,
the probability that the exact same haplotype would be
observed for FCB and Dd2 by chance over 22 different SFPs
in the region between bases 331,456 and 407,273 on
Chromosome 7 is 1 in 3.1E 11. Disequilibrium was also
noted at the same region in the comparison between FCR3
and Dd2, but was lacking in comparisons between other lines
such as HB3 and Dd2. These data suggest that haplotype
analysis of DNA derived from un-cloned drug-resistant and
drug-sensitive parasites isolated directly from patients could
indicate the chromosomal regions associated with drug
resistance. In contrast to traditional mapping methods, this
approach is not dependent on a set of pre-established
markers or specialized primer sets. The entire SFP dataset
(Tables S2 and S3), as well as a browsable interface showing
the exact location of variation in each gene in the laboratory
strains, can be viewed at http://carrier.gnf.org/publications/
SFP.
Table 1. P. falciparum Strains Used in This Analysis
Strain Origin Description Drug-Resistance Profile
b Source Reference
3D7 The Netherlands
a Laboratory SDX Prof. D. Wirth and MR4, USA [72]
FCR3 The Gambia Laboratory CQ Prof. I. Sherman [73]
FCB Thailand Laboratory CQ, QN, CYC MR4, USA [5]
7G8 Brazil Laboratory CQ, PYR, CYC MR4, USA [74]
W2 Thailand Laboratory CQ, QN, PYR, SDX MR4, USA [75]
D6 Sierra Leone Laboratory — MR4, USA [75]
Dd2 Thailand Laboratory CQ, QN, PYR, SDX MR4, USA. [18]
HB3 Honduras Laboratory PYR MR4, USA [76]
C188 HB3 3 Dd2 cross Laboratory — MR4, USA. [19]
18.02 Pikine, Senegal Field — Dr. J. Daily n/a
31.01 Pikine, Senegal Field — Dr. J. Daily n/a
41.02 Pikine, Senegal Field — Dr. J. Daily n/a
48.02 Pikine, Senegal Field PYR Dr. J. Daily n/a
51.02 Pikine, Senegal Field CQ Dr. J. Daily n/a
CQ, chloroquine; CYC, cycloguanil; PYR, pyrimethamine; QN, quinine; SDX, sulfadoxine.
aP. falciparum strain 3D7 was derived from P. falciparum strain NF54 by limiting dilution [72]. NF54 was derived from a patient living near Schipol airport in the Netherlands, who had never
left the Netherlands [77,78].
bDrug-resistance profiles were obtained from [19,55,79].
DOI: 10.1371/journal.ppat.0020057.t001
Table 2. Direct Nucleotide Sequencing of Multiple Alleles across Three Loci in the P. falciparum Strains W2 and 51.02
Strain PlasmoDB_ID Gene_ID Number of
Polymorphic
Probes Identified
Total
Number
of Probes
Number of
Non-Synonymous
Mutations
Number of
Synonymous
Mutations
Total Number
of Probes
Re-Sequenced
Number of
False-Positive
Probes
W2 PF10_0348 810505 5 68 5
a 25 0
PFE1600w 813129 3 52 3 0 3 1
PFL0800c 811213 3 22 3 0 3 0
51.02 PF10_0348 810505 7 68 7
a 27 0
PFE1600w 813129 5 52 5 0 5 0
PFL0800c 811213 3 22 4
a 03 0
Nucleotide sequences derived from independent PCR-generated DNA fragments on both strands, for the three loci in the strains W2 and 51.02, were aligned with the corresponding gene
sequences in the published P. falciparum 3D7 genome sequence [11]. Sequencing indicated a false-negative rate of ’50%, which was used in converting the SFP rate to the SNP rate. The
high false-negative rate is due to the fact that not all probes initially function well, although function is reproducible, and because SNPs outside of the central region of the 25-mer probes
sometimes do not produce an SFP. Furthermore, we used stringent parameters in our analysis in order to obtain a very low false-positive rate.
aIndicates that more than one nucleotide substitution was observed within a single polymorphic 25-mer feature.
Gene_IDs were derived from Entrez Gene at NCBI (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db¼gene).
DOI: 10.1371/journal.ppat.0020057.t002
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The ratio of SFPs to probes was highly variable depending
on a gene’s predicted function, chromosomal position, or
life-cycle stage–expression [14]. Although the number of SFPs
did not appear biased to any particular chromosome, an
uneven distribution of polymorphic features within each
chromosome was observed, as previously noted on Chromo-
some 2 [17]. Non-variable genes (more than ten probes,
,10% SFP rate) accounted for 82% of the total genes located
in the central regions of the chromosome (4,077/4,998 genes).
In contrast 7,555 (’75%) of the 10,122 probes in subtelo-
meric regions were polymorphic versus 12,978 (’5%) of the
remaining 247,910 probes (p   1.0E 100). Despite this
observation, many genes that are located in the central
regions of the chromosome show variability on an individual
basis.
Low levels of variability were also found in different
functional classes. For example, only 49 SFPs were observed
for the 2,034 probes mapped to genes having a role in protein
biosynthesis for the 13 strains interrogated. Assuming a false-
negative SFP discovery rate of 50% and no linkage, this
corresponds to one polymorphism for every ’7,000 bases in
each strain. In contrast, genes with putative roles or
associated with immune evasion (vars, riﬁns, and stevors [22])
displayed a signiﬁcantly higher estimated SNP rate of at least
one polymorphism for every 200 bases (10,746 SFPs/13,018
probes), although this may be an underestimation as one
probe may cover multiple SNPs. The fact that the majority of
genes were exceptionally well conserved across strains
supports the idea that the different strains of P. falciparum
emerged through a population bottleneck so recently that
multiple mutations have not accumulated [23,24].
Using previously published microarray data from strain
3D7, we found some correlation between the time of mRNA
expression [14] and variability, with genes that are expressed
during the parasite’s brief extra-cellular phases (merozoite
and sporozoite phases) showing almost twice the rate of
Figure 1. Mapping the Recombination Breakpoints across the 14 P. falciparum Chromosomes in the Chloroquine-Sensitive F1 Progeny Strain C188
A total of 14,289 SFPs were identified over three hybridizations by comparing HB3, Dd2, or the recombinant line C188 to 3D7. SFPs were recorded as
HB3 (green bars) in the recombinant line if the probe was scored as polymorphic in both C188 and HB3 but not Dd2, or were recorded as Dd2 (red bars)
if scored as polymorphic in Dd2 and C188 [19] but not HB3. Regions with a large number of markers scored as both HB3 and Dd2 are shown in yellow
and are associated with the known locations of var, rifin, and stevor genes (shown as blue dots). Markers determined by microsatellite length mapping
(MLP) are coloured purple and blue [7].
DOI: 10.1371/journal.ppat.0020057.g001
Figure 2. Linkage Disequilibrium surrounding pfcrt (MAL7P1.27) in FCB
and Dd2 on Chromosome 7
Scores were generated by calculating the probability of observing the
same genotype by chance over a moving 40-kbp window (with the
probability of observing the same genotype for any one SFP by chance
placed at 0.33). The plot shows the ratio between the probability and the
maximum possible probability for regions with at least four SFPs, with 1
indicating the best possible score. The position of antigenic variation
clusters (vars, stevors, or rifins), are shown in blue and are marked. SFPs
mapping to these genes were excluded from the calculations because
our data indicate that mitotic recombination may be occurring in these
genes. pfcrt, which is located between bases 307,926 and 311,020 on
Chromosome 7, is shown as a black triangle. The trough at pfcrt is likely
to be due to the strong selective pressure on pfcrt, and is consistent with
the observation that FCB and Dd2 have different alleles of pfcrt even
though published SNP data also shows disequilibrium in surrounding
regions [5]. Data for other chromosomes are shown in Figure S1.
DOI: 10.1371/journal.ppat.0020057.g002
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genes [p¼2.33E 46] and 1,043/5,396 for sporozoite-expressed
genes [p   1.0E 100]) as genes expressed during the late-
trophozoite phase when DNA replication is occurring (373
SFPs/11,751 probes) (Table S5). The diversity observed within
the genes expressed during these two extra-cellular life-cycle
stages (merozoite and sporozoite stages) may result from an
increased selection pressure from the host compared to those
parasite stages that reside within the erythrocyte. Although
we hypothesized that non-variable genes would show more
reproducible expression proﬁles across strains and across
various microarray-expression platforms, this was not the
case. The average correlation coefﬁcient for strains HB3 [25]
and 3D7 [14] across expression proﬁles for expressed asexual
erythrocytic stage genes, with SFP rates of less than 2% (more
than nine probes), was 0.75 (n ¼ 580), while for expressed
variable genes (SFP rate .10%, more than nine probes) it was
0.70 (n ¼ 99) (http://www.plasmodb.org) suggesting that
expression patterns are generally not affected by variation.
The greatest predictor of expression correlation across the
strains and platforms was relative transcript abundance, with
genes exhibiting low expression levels in the erythrocyte and
high expression levels in the gametocyte or sporozoite stages
(n ¼ 394) showing the poorest correlation (0.28).
It has been suggested that intronic sequences are under
neutral selection, and thus we calculated their SFP rates [26].
We observed a total of 309 SFPs/5,686 intronic probes,
corresponding to a polymorphism for every ’3,000 bases.
However, 76/309 intronic SFPs are found within multi-gene
families, while only 239/5,686 intronic probes are located in
variable multi-gene families described below, suggesting that
intronic sequences are not subject to neutrality when located
in multi-gene families (p ¼ 1.16E 32). This contrasts with the
results of Castillo-Davis et al., who showed that intronic
nucleotide substitution was not accelerated in duplicated
genes in their comparison of the P. yoelii yoelii and P. falciparum
genomes [26]. This discrepancy may be due to the fact that
many members of P. falciparum multi-gene families do not
have recognizable orthologs in the P. yoelii yoelii genome [27]
and were excluded from the analysis. When intron sequences
from multi-gene families are omitted, these ﬁndings suggest
that members of housekeeping families, such as protein
biosynthesis (49 SFPs/2,034 probes; SFP rate 2%), are evolving
at less than the neutral rate (233 SFPs/5,447 probes; SFP rate
4%) (p ¼ 0.000095).
Types of Variable Genes
Approximately 10% (n ¼ 457) of the genes in the malaria
genome showed SFP rates (number of SFPs/total number of
probes) of greater than 10% (with a minimum of ten
probes)—more than twice the rate of neutrality—and thus
could be classiﬁed as highly variable. These genes could be
broken down into three broad categories, including members
of multi-gene families, highly expressed immunogens (which
are predicted to be under selection from the host immune
system), and enzymes that may play a role in the parasite’s
response to drug pressure. Excluding the highly variable var,
riﬁn, and stevor genes (n ’ 290), known to be involved in
antigenic variation, we identiﬁed a total of 234 variable genes,
across all strains, with 49% (114/234 genes) containing a
signal peptide (SP) or at least one transmembrane (TM)
domain, suggesting that parasite-mediated exposure of
proteins through externalization is important to the immune
response. Of these 234 variable genes, 66 were annotated
(Table 3) whereas 168 were classed as uncharacterized (Table
S6), similar to that which was found in an analysis of SNPs on
Chromosome 3 [8]. Within the individual strains, 128 variable
genes were identiﬁed in the laboratory strains and 86 in the
Senegal isolates (Tables S7 and S8). Interestingly, many of the
best characterized P. falciparum genes (circumsporozoite [CS]
protein, sporozoite surface protein 2, MSPs, erythrocyte-
binding antigens) and genes associated with drug resistance,
such as the P. falciparum chloroquine-resistance transporter,
pfcrt (MAL7P1.27), reside within the highly variable, annotated
genes that we identiﬁed (Table 3).
Multi-Gene Families
We hypothesized that the presence of a paralog would
predispose a gene to a loss of the 3D7 haplotype [28,29].
Gene-conversion events, which result in small rearrange-
ments between different alleles or paralogs of the same gene,
are the result of the cell’s repair of a double-strand break
(reviewed in [30]). In yeast, introducing a paralog can increase
the rate of gene conversion [31]. In haploid, asexually
replicating eukaryotic organisms such as P. falciparum or
Saccharomyces cerevisiae, a double-strand break would likely
result in cell death if the break occurred in a gene without a
paralog that could be used in the repair process. However, if a
paralogous gene were available for repair, the event would
likely not be lethal, and evidence of the repair event would
remain in the genome as a novel allele. It is also feasible that
the presence of a paralog promotes higher rates of non-
homologous recombination [29]. Indeed, one of the strongest
predictors of whether an uncharacterized gene would show
excessive variability was whether or not it was assigned an
ortholog/paralog group [32] (11,862 SFPs/23,781 probes for
genes having a paralog versus 8,671 SFPs/234,251 probes for
genes lacking a paralog (p   1.0E 100). In fact, members of
multi-gene families showed a 20-fold enrichment in the group
of highly variable genes, relative to the genome as a whole,
and a 5-fold increase (1,462 SFPs/11,048 probes; p  
1.0E 100) after members of the var, riﬁn, and stevor multi-
gene families were excluded (10,746 SFPs/13,018 probes).
While it may be possible that hybridization-based methods
cannot be used to examine variability in multi-gene families,
sequencing of PF10_0348, a member of the MSP family, and
PFE1600w, a member of the ring-infected erythrocyte surface
antigen (RESA) family, showed almost 100% ﬁdelity in all
polymorphisms scored (Table 2).
Although variation in vars, stevors, and riﬁns was expected,
we identiﬁed other groups of consistently variable genes, such
as one which contains 13 members (ortholog group 762970
[32]), almost all of which show extensive variation (in terms of
SFPs) across the strains that we have examined (315 SFPs/
1,051 probes). This gene group displays some homology to the
P. knowlesi schizont-infected cell-agglutination variant antigen
(SICAvar) multi-gene family. All members (n¼13) of this gene
family have previously been designated as the surf genes
(surface-associated interspersed genes) [33], which encode a
protein family, SURFINs, present on the surface of the
infected erythrocyte and merozoite. The high degree of
variability observed within these surface antigens implies that
members of the surf gene family are likely to be evolving at
higher rates [34] relative to the neutral polymorphism rate
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them in antigenic variation.
Other variable gene families include a recently identiﬁed
multi-gene family called the Maurer’s cleft proteins, which
are trafﬁcked to the surface of infected red cells [35]
(ortholog group 765506 [32]) and showed variation at 29 of
the 48 probes speciﬁc for this gene family. Some of the
variable gene families may be related to human physiology: of
the 12 genes that show an over-expression of mRNA
transcripts in vivo compared to in vitro [36], nine are
members of multi-gene families that show variation. One of
these genes (PF14_0752), encodes an uncharacterized pro-
tein that is member of a 32-member multi-gene family
(ortholog group 774486 [32]). A total of 91 SFPs/319 probes
are variable within this ortholog group. Generally, a
proportion of these multi-gene families show variation of
mRNA expression of family members between different P.
falciparum strains, suggesting that selective transcriptional
silencing may further regulate their expression.
As previously noted, relatively conserved var genes have
also been observed and are associated with binding to the
host receptor, chondroitin sulfate A (CSA) [37–39]. Immu-
noepidemiologic evidence has suggested that this particular
var gene variant is conserved between isolates and that it is
implicated in malaria infection during pregnancy [37]. Of the
polymorphism data available for approximately 70 of the
annotated var genes, 17/70 genes showed signiﬁcantly less
variability (less than ten SFPs) than the remaining 53 genes,
such as the previously characterized var2CSA gene PFL0030c
[37]. Eleven out of 17 of these ‘‘conserved’’ var genes are
annotated as truncated coding sequences, and one as a
‘‘pseudogene’’. The inactivation of these coding sequences
over time may be a cause or consequence of their speciﬁc role
in malaria pathogenesis.
Immunogens
Since certain blood-stage antigens of the malaria parasite,
such as MSP-1 (PFI1475w), are highly expressed when the
parasite invades the erythrocyte, they are likely to be under
selection pressure from the host, and consequently are
believed to display elevated rates of nucleotide substitution
compared to the genome as a whole [40]. Such variable genes
are thought to be the principal targets of protective
immunity. To test the hypothesis that such genes would be
under positive selection, we compared the SFP rate of
probable immunogens to housekeeping genes. The SFP-to-
probe ratio was signiﬁcantly higher for characterized parasite
immunogens in clinical development (CSP [PFC0210c]; TRAP
[PF13_0201]; LSA1 [PF10_0356]; LSA3 [PFB0915w]; MSP-1
[PFI1475w]; MSP-2 [PFB0300c]; MSP-3 [PF10_0345]; AMA1
[PF11_0344]; SERA [PFB0340c]; GLURP [PF10_0344]; RESA
[PFA0110w]; and EXP1 [PF11_0224] [2] (220 SFPs/882
probes), compared with either housekeeping genes (such as
those with roles in protein biosynthesis [49 SFPs/2,034 probes;
p ¼ 4.62E 76]) or compared with genes encoding proteins
that are localized to the mitochondrion (114 SFPs/4,185
probes; p ¼ 3.24E 94). Seven of these 11 characterized
immunogens encode genes that are amongst the top 20 most
highly variable, non-deleted annotated genes (Table 3); a
’17-fold enrichment in the group of highly variable genes is
shown relative to the genome as a whole. Between the 14 P.
falciparum strains analyzed, strains Dd2 (Thailand), FCR3 (the
Gambia), and FCB (Thailand) display the highest levels of
polymorphisms in characterized parasite immunogens, while
strains D6 (Sierra Leone) and 7G8 (Brazil) showed low levels
of variation at these speciﬁc loci (Table S9). Overall, the
laboratory strains show greater variation at these 11 loci
compared to the Senegal strains, particularly at the MSP-1
locus (PFI1475w) (Table S9).
A conserved pentameric sequence (Pexel motif) [41] and an
11-amino acid signal (host-targeting [HT] motif) [42], which
are frequently found in parasite proteins that are targeted to
the red blood cell, have been identiﬁed, and such proteins
have been proposed as candidates for proteins interacting
with the host immune system. Excluding the highly variable
var, riﬁn, and stevor genes, we observed a large enrichment for
polymorphisms in genes for those proteins bearing a Pexel
motif (609 SFPs/4,401 probes versus 9,178 SFPs/240,613
probes; p ¼ 2.63E 157) or a HT motif (381 SFPs/2,983 probes
versus 9,406 SFPs/242,031 probes; p ¼ 7.75E 88) versus those
that do not, although not all proteins bearing this signal show
variation.
Based upon these observations, it is our hypothesis that
many of the uncharacterized genes that show similar patterns
of variability and gene expression to known antigens, such as
MSP-1 (PFI1475w) or the CS protein (PFC0210c), also interact
with the host immune system. Indeed, volunteers protected
with an irradiated sporozoite vaccine all exhibited an
immune response to the product of PFL0800c [43], a gene
that shows a life cycle–dependent expression pattern that is
similar to the well-characterized P. falciparum pre-erythrocytic
stage antigen, the CS protein (PFC0210c), and which we
demonstrate exhibits a comparable degree of variation (four
SFPs/22 probes versus ﬁve SFPs/25 probes).
Drug Resistance
While single point mutations in drug targets and receptors,
which may not be identiﬁed by our analysis, can result in drug
resistance, evidence suggests in some cases that multiple
mutations are associated with resistance [44]. This may be
because resistance mutations impose a ﬁtness disadvantage
and additional, compensatory mutations are required for
resistance or to maintain a protein’s 3D structure. It is known
that the P. falciparum chloroquine-resistance transporter
(pfcrt) (MAL7P1.27) shows a high rate of substitution with at
least 15 different known haplotypes and 15 non-synonymous
sites in a 424-amino acid protein [45]. In contrast, introns of
housekeeping genes show low SNP rates (one SNP/27,000
bases) [23]. The list of highly variable genes (Table 3) includes
t h eg e n et h a ti sk n o w nt op l a yar o l ei nm o d u l a t i n g
antimalarial drug resistance, the P. falciparum chloroquine-
resistance transporter (pfcrt) (MAL7P1.27) (four SFPs/36
probes; 11% SFP rate) [46]. The well-known drug-resistance
gene dihydrofolate reductase (dhfr) (PFD0830w) [47], also
shows an increased rate of variability (ﬁve SFPs/54 probes; 9%
SFP rate) compared to the neutral rate (4%) [24].
As many antimalarials are derived from natural products
that are likely to have off-target effects and to contribute to
parasite toxicity, other enzymes that display variation (Table
3) may represent additional off-site targets. Such candidates
potentially include heme A farnesyltransferase (PFE0970w)
(seven SFPs/52 probes; 13 % SFP rate) or the heme-binding
protein (PFI0885w) (three SFPs/17 probes; 17% SFP rate),
which could be targeted by antimalarials that bind to heme
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Plasmodium falciparum Genetic Variationderivatives, such as chloroquine and an ADP/ATP carrier
protein (PF10_0051) (seven SFPs/32 probes; 21% SFP rate),
which could modulate resistance to drugs targeting mito-
chondrial function, such as Atovaquone. A few non-enzymes
that are not paralogs and do not contain a TM or SP domain
were also variable. These non-SP/TM–containing proteins
include the 50S (PF07_0046) and 60S (PFE0845c) ribosomal
proteins. As many antibiotics target the ribosomal subunits,
this variation may represent increased selection from
indiscriminate antibiotic usage in the human host.
Gene Amplifications
Notably absent from the list of highly variable genes (Table
3) was the P. falciparum multidrug-resistance gene, pfmdr11
(PFE1150w), which has been implicated in meﬂoquine
resistance in both human [48] and rodent malaria infections
[49]. This was not unexpected since it is ampliﬁcations of the
pfmdr1 gene that are associated with resistance, and we
required all SFPs scored to show a higher signal in 3D7
relative to the alternate strain. Our analysis of hybridization
ratios (see Materials and Methods) conﬁrms the known pfmdr1
ampliﬁcation in the meﬂoquine-resistant strain Dd2 [50], and
shows independent ampliﬁcation events in strains FCR3 and
FCB (Table 4). We are also able to detect further gene
ampliﬁcations in other regions. For example, gene duplica-
tion is noted in the strain W2 encompassing the PfRH1 gene
(PFD0110w) on Chromosome 4 [51] and in the center of
Chromosome 7. Our data identiﬁed an increased hybrid-
ization intensity surrounding the GTP cyclohydrolase gene
(PFL1155w) on Chromosome 12 in seven out of the 14 strains
analyzed (Table S10). GTP-cyclohydrolase encodes the ﬁrst
enzyme in the folate biosynthesis pathway. The folate path-
way is the target of many antimalarials (Fansidar, WR99210,
sulfadoxine, and pyrimethamine), chemotherapy agents
(Methotrexate), and antibiotics (sulfa drugs). The mechanism
of resistance to antifolates in vivo has been attributed to
mutations within either the dihydrofolate reductase (dhfr)
(PFD0830w) [47] or dihydropteroate synthase (dhps)
(PF08_0095) genes [52], but mutations in the dhps gene may
not always correlate with sulfadoxine resistance [53].
Although the regions surrounding the GTP cyclohydrolase
gene (PFL1155w) appeared to be ampliﬁed, the median signal
for all probes to GTP cyclohydrolase itself was actually
signiﬁcantly lower in the majority of strains relative to 3D7,
suggesting an undiscovered ampliﬁcation in this reference-
sequenced strain (Figure 3).
Real-time PCR analysis of the GTP-cyclohydrolase gene
(PFL1155w), along with a b-tubulin control gene
(PF10_0084), conﬁrmed the independent ampliﬁcation of
this gene in 3D7 and in the P. falciparum strains W2, HB3, FCB,
D6, 7G8, and Dd2 but not in FCR3 or any of the ﬁve strains
isolated from Senegal (Table S11). Interestingly, it has been
shown that the expression of bacterial GTP cyclohydrolase-1
in transgenic Arabidopsis results in a 1,250-fold and 2- to 4-fold
enhancement in the levels of pterins and folates, respectively,
suggesting that this is the rate-limiting enzyme in plants [54].
The presence of the ampliﬁcation in most laboratory strains
may indicate the importance of de novo folate biosynthesis in
culture. However the absence of this ampliﬁcation in the
Senegal strains may also correlate with a lack of selection
pressure in these recently acquired isolates, since antifolate
drug regimes replaced chloroquine in Pikine, Senegal, only
Table 4. Description of the Genes Amplified in the P. falciparum Strains Analyzed
Strain Duplicated Region Function Representative Genes in Duplicated Region
FCB PFL1130c..PFL1165w Folate biosynthesis GTP cyclohydrolase I, uncharacterized protein, ribosomal protein L24
HB3 PFL1125w.. PFL1315w Proliferating cell nuclear antigen (PCNA), cytochrome c heme lyase,
putative, GTP cyclohydrolase I
7G8 PFL1130c..PFL1160c GTP cyclohydrolase I, uncharacterized protein, ribosomal protein L24
3D7 PFL1155w GTP cyclohydrolase I
W2 PFL1145w..PFL1160c GTP cyclohydrolase I, uncharacterized protein, ribosomal protein L24
Dd2 PFL1145w..PFL1155w GTP cyclohydrolase I, cAMP-dependent
protein kinase subunit, ribosomal
protein L24, DNA GyrAse subunit,
phospholipid-transporter ATPase
FCB PFD0090c..PFD0120w Surface proteins Reticulocyte-binding protein, uncharacterized proteins
HB3 PF11_0504..PF11_0513 RESA and RESA-2
W2 PFD0100c..PFD0115c; MAL7P1.52;
PFL1365w.. PFL1385c
Reticulocyte-binding protein, uncharacterized proteins; RIF pseudogene;
NIMA-related protein kinase (Pfnek-1), 101 kd malaria antigen
D6 PF07_0135 Rifin
31.01 PF10_0006..PF10_0013 Hypothetical proteins, pfemp1
FCB PFE1065w..PFE1155c Antimalarial drug resistance S-adenosylmethionine-dependent methyltransferase,
multidrug-resistance protein, pfmdr1
FCR3 PFE0940c.. PFE1175w Adenosylhomocysteinase(S-adenosyl-L-homocysteine hydrolase),
S-adenosylmethionine-dependent methyltransferase, pfmdr1,
cytochrome c oxidase assembly protein (heme A:
farnesyltransferase), putative, vacuolar ATP synthetase, putative
Dd2 PFE1095w.. PFE1160w S-adenosylmethionine-dependent
methyltransferase, putative, pfmdr1
FCR3 PFL0115w..PFL0130c Cyclophilins Cyclophilin, uncharacterized proteins
W2 MAL7P1.137.. PF07_0106 Others Mago nashi protein homolog, kelch protein, exonuclease i
No gene amplifications were observed in the P. falciparum strains 18.02, 41.02, 48.02, and 51.02 isolated from Senegal.
DOI: 10.1371/journal.ppat.0020057.t004
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Plasmodium falciparum Genetic Variationafter the isolation of the strains used in this analysis. From the
literature, it appears that this gene ampliﬁcation correlates
with the sulfadoxine-resistance proﬁle previously published
for particular strains analyzed [55–57]. We propose that
partial sulfadoxine and/or pyrimethamine resistance may be
linked to duplication of GTP cyclohydrolase (PFL1155w),
which may permit an increased metabolic ﬂux through the de
novo pathway, although further investigation of a larger
number of strains is required to conﬁrm this association.
Additional analysis of this duplication event from recently in
vitro–adapted isolates in other geographic areas, as well as
the continued analysis for the appearance of GTP-cyclo-
hydrolase duplication in the Senegal strains over time (both
in vivo and in vitro), will also be required.
Gene Deletions
Previous studies have shown that arrays can be used to
identify potential deletions using a comparative genome-
hybridization approach that examines the ratios between the
hybridization signals for two strains [25,58]. However, such a
method makes it difﬁcult to distinguish between a deletion
and those cases where a gene is simply highly variable in one
strain. The problem is compounded if only one or two probes
per gene are used [25] versus the scores of probes used in
these analyses. Here we use an algorithm, based on the match-
only integral distribution (MOID) algorithm that returns a
‘‘present’’ call based on whether a probe-set distribution for a
gene is similar to a series of background control probes [59]
on the array. These control probes, which are not expected to
hybridize to human or P. falciparum sequences, are predicted
to have little signal associated with them and to show the
same patterns as ‘‘deleted’’ genes. Analysis of background
sequences indicated that they only had a 2% chance of being
misclassiﬁed as ‘‘present’’, and thus provides an estimate of
the number of likely false positives.
In applying this algorithm, every gene with at least six
probes (n ¼ 4,954) was considered present for 3D7 indicating
a low false-negative rate as well, although gene-duplication
events in strains other than 3D7 could mask the deletion of a
very closely related gene (Table S12). While one might predict
that highly variable genes might not be called ‘‘present,’’ the
Figure 3. The Heat Map Shows the Base 2 Logarithm of the Ratio of the Normalized, Background Subtracted Probe Signal for the Listed Isolate (18.02,
Dd2, 7G8 or HB3), Relative to the Sequenced Isolate, 3D7
All probes on the array were selected to be unique within 3D7. Each horizontal bar represents a single gene on the right arm of Chromosome 12. Dark
probes, with low signal intensities, do not match any region in the genome of the listed isolate, while light probes, displaying high signal intensities,
such as those near the GTP-cyclohydrolase gene (PFL1155w) in Dd2, HB3, and 7G8 contain matches to multiple regions of the genome. The signal
intensity and the consecutive nature of the pattern suggest that strains 7G8, HB3, and Dd2 contain more than one copy of the GTP-cyclohydrolase gene
PFL1155w. An arrow represents the location of the GTP-cyclohydrolasePFL1155w gene on Chromosome 12.
DOI: 10.1371/journal.ppat.0020057.g003
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Plasmodium falciparum Genetic Variationdeletion analysis showed that hybridization to variable genes,
even for the most variable var, riﬁn, and stevor genes, is
generally higher than the background level (Figure 4; Table
S9). For example, PF10_0348 bears 23 SFPs/68 probes and is
considered to be highly variable in our analysis. The MOID
algorithm–derived E value for this gene ranged from 124 to
269 units with ‘‘present’’ p-values in the range of 1.0E 17 to
1.0E 47. In contrast, genes within the previously character-
ized 42-kbp deletion in P. falciparum strain W2 showed
different patterns [17,60]. This deletion is likely to be
associated with a loss of cytoadherence in parasite lines
maintained in in vitro culture. The signal for PfEMP3
(PFB0095c), a gene in this region, ranged from 200–792 units
in strains where it was considered present and from 18.1 to
4.6 units in strains where it was considered deleted. The p-
values were in the range of 1.0E 222 for strains where it was
considered present and from 1.0E 3.6 to 1.0E 1 where it was
considered deleted. These differences are remarkable and
allow a high degree of conﬁdence in calling deletions.
We also identify deletions (Table S13) in several genes on
the right arm of Chromosome 9 in strains FCR3 and FCB,
including those encoding an enzyme (PFI1800w), an unchar-
acterized protein (PFI1785w), and the cytoadherence-linked
asexual protein (CLAG, PFI1710w) [61]. The Maurer’s cleft
proteins [35], which co-localize with a 130-KDa membrane-
associated protein found in both the Maurer’s clefts and
knobs, but only in a cytoadherent P. falciparum strain [62]
(thus indicating a potential role in cytoadherence) were also
often deleted. Despite the conﬁdence that our method offers,
difﬁculties in distinguishing a full deletion from a large
partial deletion or substitution do exist, particularly for large
genes such as MSP-1 (PFI1475w). The MSP-1 gene, to which
there are 162 probes, was considered ‘‘absent’’ in one strain
(HB3), although visual inspection of the gene showed a
residual signal at the 3 prime end of the gene, consistent with
the known 3 prime conservation of this well-studied
immunogen. Because most other deleted genes were located
in chromosomal clusters and were themselves adjacent to
other deleted genes, which was not true for the S-antigen
(PF10_0343) and MSP-1 (PFI1475w), our conﬁdence in
calling these genes ‘‘absent’’ is decreased. Efforts to PCR-
amplify the entire 10-kbp MSP-1 region using primers
outside of the variable regions were not successful.
Discussion
Two recent studies examined selection in the P. falciparum
genome: the ﬁrst measured codon volatility [63], and the
second identiﬁed orthologous gene sequences under selec-
tion through comparative sequencing of rodent parasite
genomes [64]. A lack of correlation was observed between
each gene’s average SFP value, as determined by this study,
Figure 4. Example of a Deleted Region
Hybridization levels were calculated with the MOID algorithm as previously described [59]. The figure shows the signal for 26 genes beginning with
PFB0010w and ending with PFB0120w for three strains (41.02, 3D7, and C188). The background level (zero) was determined by analyzing the signal of
non-P. falciparum genes on the array. Data for all genes and all strains are available from Table S12.
DOI: 10.1371/journal.ppat.0020057.g004
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¼ 0.06, Pearson’s correlation) or the dN/dS ratio (r ¼ 0.01,
Pearson’s correlation). However, because of the fundamental
differences in the datasets and experimental approaches, we
did not expect to observe a correlation. While the codon-
volatility data measurement should be comparable, various
groups have suggested that codon volatility makes unfounded
assumptions about underlying mutational processes and is
potentially not a robust approach to detect selection [65–67].
Secondly, Hall et al. [64] examined speciation events that
occurred over a much larger time scale, while our data
consider events that likely occurred more recently, poten-
tially within the past 50 y. Furthermore, only 20% of the
highly variable P. falciparum genes have detectable orthologs
in the rodent malaria species, and only 13 out of the 77 genes
showing a dN/dS ratio of .1 between P. berghei and P. chabaudi
have an orthologous gene sequence present in P. falciparum
(versus 70% of all genes). However, integrating the rodent
dataset with our variability data may allow better prediction
of potential drug-resistance genes. Characterized P. falciparum
enzymes such as dhfr, orotidine monophosphate dehydrogen-
ase, and heme A farnesyltransferase show very low dN/dS
ratios but high rates of variability in our assay, suggesting
roles in drug resistance.
These data may also be useful to systems biology research.
Traditional gene-by-gene approaches to understanding gene
function are difﬁcult and time-consuming in P. falciparum.
Systematic genome-wide analyses such as those described
here can assist in the credentialing of genes to identify the
most promising drug and vaccine targets. As with expression
patterns, protein–protein interaction maps, or global-local-
ization studies, the SFP rate offers an insight as to the
potential function of uncharacterized genes; the SFP rate may
indicate that a gene is likely to be involved in antigenic
variation, that it is interacting with the host’s immune system,
or that it is evolving under drug pressure. Probes that tile
through the P. falciparum genome can now be placed on a
single microarray, which should permit the identiﬁcation, at a
higher resolution, of genes that are changing in response to
the introduction of new drug treatment regimes, such as new
artemisinin-based combination therapies [68]. Even if a single
gene cannot be identiﬁed as being differentially under
selection when comparing treated and untreated parasite
populations, hybridization haplotypes associated with drug
resistance [69,70] will likely be found. These data will also
assist in the interpretation of traditional mapping data,
because it is likely that SNPs in genes that are highly variable,
or members of multi-gene families, will be less reliable than
those that lie in genes that are largely monomorphic.
These data also shed light on the time of P. falciparum
speciation. If one considers just the average number of SNPs
[8] or SFPs, as in this study, the P. falciparum species appears
ancient, but after excluding variation in genes that are likely
to be evolving by mitotic recombination, the species looks
considerably younger. While much additional work will be
clearly required to conﬁrm associations between mutations
and resistance to individual drugs, such connections, if
supported, will allow the design and implementation of more
effective therapies. Ultimately, some of these genes involved
in drug resistance, particularly those whose copy number is
critical to parasite survival, may become the targets of novel
drugs to treat malaria.
Materials and Methods
P. falciparum Affymetrix full-genome array. Although useful for
gene-expression analysis, the malaria full-genome oligonucleotide
array [14] was speciﬁcally designed for studying diversity in P.
falciparum. The design was optimized so as to produce as many
nonoverlapping probes in coding regions as possible. The array
contains 327,989 speciﬁc single-stranded 25-mer probes, of which
281,552 map to the exons of 5,179 genes that comprise ’55% of the
23-Mbp genome. After excluding overlap between probes and
repetitive regions (’18% of the coding sequence), on average more
than 53% of the exon sequences are covered by at least one probe.
Probe coverage is signiﬁcantly lower in the intragenic regions
because of the frequency of repetitive sequences and the high AT
content (up to 90%). Of the 327,989 single-stranded probes, 29,207
are perfect reverse complements of another. Because forward and
reverse probes do not always exhibit identical hybridization behavior,
the forward probe might be capable of revealing an SFP while its
complement might not. Thus, reverse-complement probes were
excluded from the SFP tally only if both the forward and the reverse
complement detected an SFP. Reverse complements were excluded
from the number of probes per genes listed in Tables 1–4.
DNA methods. P. falciparum parasites were cultured in leukocyte-
depleted human O
þ erythrocytes as previously described [71], and
genomic DNA was isolated by standard phenol–chloroform extrac-
tion. RNA contamination was removed by treatment with RNAse at
37 8C for 1 h.
Genomic DNA (15 lg) from each P. falciparum strain (Table 1) and
2.5 ng each of Bio B, Bio C, Bio D, and Cre control plasmids were
fragmented by treatment with DNase 1 and end-labeled with biotin
[12]. Hybridization was subsequently carried out to the P. falciparum
full-genome array [14] at 45 8C overnight, followed by a standard wash
protocol and antibody staining (Affymetrix, Santa Clara, California,
United States) and detection with streptavadin R-phycoerythrin
conjugate and normal goat IgG. Arrays were scanned with an
emission wavelength of 560 nm at 3-lm resolution using a confocal
scanner (Affymetrix), and the signal intensity for each feature on the
array was determined using the 70th percentile method in Microarray
Suite 5 (Affymetrix). Three replicate hybridizations for each strain
were carried out.
Identiﬁcation of SFPs. SFPs were identiﬁed as described in
Winzeler et al. [12]. Grids were aligned to the scanned images by
the known feature dimensions of the array. The hybridization
intensities for each of the elements in the grid were determined by
the 75th percentile method in the Affymetrix GeneChip software
package.
For each hybridization, an adjusted array-hybridization intensity
value (I) was determined as the mean of the log signals of all features
that showed minimal variation across all hybridizations. Then, for
each feature on the array, a linear regression of the logarithm on I for
all hybridizations was determined by the least-squares method, ﬁrst
under the null hypothesis that the reference (P. falciparum strain 3D7)
and test P. falciparum strains had the same response and then under
the alternative hypothesis that the reference (3D7) strain had a
greater signal than the test strain. The models were compared with
the F-test, and the same signal model was rejected in favor of a
marker with 99% conﬁdence.
Gene ampliﬁcations and deletions. Gene ampliﬁcations were
identiﬁed by comparing an array hybridized with DNA for each
strain to an array that had been hybridized with 3D7 DNA.
Comparisons were made between arrays that appeared to be overall
closest to one another in overall signal. As a ﬁrst step, background
was subtracted from probe signals, and overall array signals were
normalized as previously described for the two arrays to be compared
[14]. Background values were determined by analyzing nonhuman,
non-P. falciparum control sequences on the array, also as previously
described [14]. This step places the overall signal intensities of arrays
in the same range as one another, but does not take into account the
fact that strains that are different from the sequenced strain, 3D7, are
expected to give an overall lower intensities because they contain
SFPs. Thus, we computed an additional normalization factor, N
(usually resulting in a 5% to 10% change). This was calculated by
computing the log2 of the median signal ratio between the test strain
and 3D7 for all probes to all genes that contained no SFPs in any of
the strains analyzed (’1,400 genes). In addition, probes with negative
values in 3D7 or the test strain, or which showed log2 ratios of more
than 4 or less than  4, were discarded.
The median value for all probe-sets was chosen as N. To identify
duplications, all 3D7 probe values were multiplied by N, determined
independently for each strain. Then the log2 of the ratio (R) of the
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each probe in each probe-set. In order to eliminate probes
complementary to SFPs or which could behave as outliers, for each
probe-set, probes were discarded if R was greater than 4 or less than
 4. A paired t-test was performed on the R values for the remaining
probes in the probe-set using p   0.01. Next, we identiﬁed genes with
a median R of greater than 0.7 for the remaining probes when the
number of remaining probes was greater than six and the t-test
indicated a likely difference between the intensities of the probe
signal for 3D7 relative to test strain. The t-test was added in order to
distinguish between a probe-set being ampliﬁed and a probe-set
being polymorphic at only several probes. The value of 0.7 (roughly a
1.5-fold increase in signal) was determined empirically, and is slightly
less than the expected 2-fold change because array probe signals are
not expected to be perfectly linear with respect to copy number, and
because the ratios for ampliﬁed genes are expected to show a
distribution of values. A comparison of the HB3 and 3D7 ratios
(Figure S2) shows a tight distribution around zero, as expected, with a
secondary peak around 0.8. Genes with values of greater than 0.7 in
the histogram are found exclusively in two chromosomal blocks; one
surrounding GTP cyclohydrolase (PFL1155w) on Chromosome 12 and
one on Chromosome 11 at the PF10_0374 locus. However, while this
method worked well for our data, it may not work as well for
saturated arrays or low-intensity arrays. Potential duplications were
visually examined to verify that the regions showed contiguous
increases in signals. Short ampliﬁcations of small genes may have
been missed.
To identify potential ampliﬁcations in 3D7, we compared the list
of genes showing a 1.5-fold or greater change in 3D7 relative to each
of the Senegal isolates (n¼5) as described above. This returned some
genes that were likely to be highly polymorphic in individual Senegal
strains, but such deletions were not held in common by all. Only two
genes were shared by all the Senegal strains examined. These two
genes were for GTP cyclohydrolase (PFL1155w) and P. falciparum 11-1
protein PF10_0374, the gene11-1 product, which is highly expressed
during gametocytogenesis. Examination of the ratios for these genes
(Table S7) is consistent with a 3D7 ampliﬁcation (generally from 1.5-
to 4-fold changes) rather than a Senegal deletion where ratios show a
20-fold difference in signal. Quantitative real-time PCR analysis
further conﬁrmed a probable ampliﬁcation in 3D7 for GTP cyclo-
hydrolase (Table S8).
In contrast, gene deletions were identiﬁed as follows. The custom-
designed Affymetrix malaria full-genome array consists of 2,397
probes for 100 viral genes that serve as background controls [14].
Intensities from these probes represent the level of cross-hybrid-
ization for a deleted gene. A new probe-to-gene map was generated
to include both sense and antisense probes, and the MOID
algorithm [59] was applied to assign ‘‘present’’ and ‘‘absent’’ calls
to each gene. Based on all the background control data collected in
this study, this analysis, similar to that described in Le Roch et al.
[14], shows that a deleted gene has only a 2% chance to be
misclassiﬁed as ‘‘present’’ if it is required to have both an intensity
level of E . 10 and a Kolmogorov–Smirnov test of log10P of less
than  0.5. Excluding genes with less than six probes and the highly
variable var, riﬁn, and stevor genes, we found a total of 33 genes being
called ‘‘absent’’ in at least two out of the three hybridizations for
each strain (Table S9).
Mapping inheritable markers. SFPs were identiﬁed in the strains
Dd2, HB3, and C188, relative to 3D7 as described above. The
inheritance of markers was determined by creating a matrix
containing the SFP data for the two parental strains (Dd2 and HB3)
and the progeny strain C188. The data were scored accordingly: if a
marker is present in Dd2 and in the recombinant, but not in HB3,
score as Dd2, but if a marker is in HB3 and the recombinant, but not
Dd2, score as HB3. These data were then plotted relative to
chromosome position, and subsequently potential recombination
breakpoints could be clearly deﬁned.
Analysis of gene-expression data. A tab-separated text ﬁle
containing the correlation coefﬁcient of expressed asexual eryth-
rocytic genes across the P. falciparum strains 3D7, HB3, and Dd2,
derived from the Affymetrix high-density oligonucleotide and glass-
slide oligonucleotide microarray-expression platforms was obtained
from PlasmoDB (http://www.plasmodb.org; Chris Stoeckert, personal
communication). The average correlation coefﬁcient of highly
variable, expressed erythrocytic genes between strains 3D7 (Affyme-
trix platform, Winzeler laboratory) and strain HB3 (glass-slide
platform, DeRisi laboratory) were derived.
Real-time PCR analysis. GTP-cyclohydrolase (PFL1155w), the
uncharacterized protein (PFL1145w), ribosomal protein L24
(PFL1150c), and pfmdr1 (PFE1150w) copy number were assessed by
real-time PCR ampliﬁcation using the BioRad MyiQ apparatus
(Hercules, California, United States) in the presence of SYBR-green.
The following oligonucleotide primers were designed to speciﬁcally
amplify each gene: PFL1155w-F 59-AAACACCATCTTTTACCTTTT
GAA-39; PFL1155w-R 59-AGCATCGTGCTCTTTAACTCC-39;
pfmdr1-F 59-CAAGCGGAGTTTTTGCATTT-39;p f m d r 1 - R5 9-
TTGAGCGCTTTGACTGAATC-39; b-tubulin-F 59-
TCGTCAACTTCCTTTGTGGA-39; b-tubulin-R 59-TCCCATTCC
CACGTTTACAT-39; PFL1145w-F 59-GGGTATGCCCCTGGAAG
TAT-39; PFL1145w-R 59-TCCACATGCTCCACCAATAA-39;
PFL1150c-F 59-ACGCAAGAAATGCCTATTCA-39; and PFL1150c-R
59-CTTTGATGGGAGGCCCTATT-39. Parallel ampliﬁcation reac-
tions were carried out in 96-well plates in 25 ll containing 0.5 lm
of each forward and reverse primer, 1 ll of template DNA, and 12.5 ll
of iQSYBR green PCR master mix (50 mM KCl, 20 mM Tris-HCl, 0.2
mM each dNTP [dATP, dCTP, dGTP, and dTTP], 0.6U iTaq DNA
polymerase, 3 mM MgCl2, SYBR Green I, 10 nM ﬂuorescein) (BioRad).
Forty cycles were performed (95 8C 10 min, 95 8C1 0s ,5 58C3 0s ,6 0
8C 30 s) (Table S11).
Nucleotide sequencing. Oligonucleotide primers were designed to
speciﬁcally amplify polymorphic regions of the PF10_0348,
PFL0800c, and PFE1600w coding sequences (Table S14). Independent
PCR-generated DNA fragments from both strands were sequenced
using dRhodamine-labeled terminators. Nucleotide sequences were
edited using the 4Peaks DNA analysis program v1.6 (http://www.
mekentosj.com/4peaks).
Statistical analysis. The Fisher’s exact test (http://www.matforsk.no/
ola/ﬁsher.htm) was used to determine the statistical relationship
between each of the categorical variables in this analysis.
All the P. falciparum 3D7 genome data and gene annotations used
for analysis in the work described in this paper are available for
download at http://www.plasmodb.org. The gene-identiﬁcation num-
bers (Gene_ID) were derived from Entrez Gene at NCBI (http://www.
ncbi.nlm.nih.gov/entrez/query.fcgi?db¼gene).
Supporting Information
Figure S1. Linkage Disequilibrium Analysis
Shown is the linkage disequilibrium analysis of SFP-derived hap-
lotypes obtained from 4,369 SFPs distinguishing the chloroquine
resistant strains FCB and Dd2, across the 14 P. falciparum chromo-
somes. Scores were generated by calculating the probability of
observing the same genotype by chance over a moving 40 kb window
(with the probability of observing the same genotype for any one SFP
by chance placed at 0.33). The plot shows the ratio between the
probability and the maximum possible probability for regions with at
least four SFPs with 1 indicating the best possible score. The position
of antigenic variation clusters (vars, stevors or riﬁns), are shown in blue
and are marked. SFPs mapping to these genes were excluded from the
calculations because our data indicates that mitotic recombination
may be occurring in these genes. pfcrt, which is located between bases
307,926 and 311,020 on chromosome 7 is shown as a black triangle. A:
Chromosomes 1–7, B: 8–14.
Found at DOI: 10.1371/journal.ppat.0020057.sg001 (2.4 MB PDF).
Figure S2. A Ratio Histogram of the HB3/3D7 Signal Intensities
As expected, a tight distribution around zero is observed, with a
secondary peak around 0.8, for 4,300 genes with more than six
probes, excluding the var, riﬁn, and stevor genes. Genes with log2 ratios
of greater than 0.7, and classed as gene ampliﬁcations in HB3, are
found exclusively in two chromosomal blocks: one on Chromosome
12 surrounding the GTP-cyclohydrolase gene (PFL1155w) and one on
Chromosome 11, encompassing the region from PF11_0504 to
PF11_0513.
Found at DOI: 10.1371/journal.ppat.0020057.sg002 (22 KB TIF).
Table S1. Probe File (38Mb) for the SCRmalaria Array
This ﬁle contains data for 327,989 P. falciparum-speciﬁc 25 mer probes
selected for use in this analysis. Probes located in both the coding and
non-coding sequences from both strands are included. Non-speciﬁc
and un-mapped probes have been removed. This ﬁle does not
contain any probes from the Plasmodium yoelii sequence. Affymetrix
standard control probes and probes from human and mouse are
marked as ‘‘controls’’ in the ‘‘Reporter Usage’’ column. Generic
mismatches are marked as ‘‘background’’ in the ‘‘Reporter Usage’’
column.
Found at DOI: 10.1371/journal.ppat.0020057.st001 (6.2 MB ZIP).
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This tab-separated ﬁle shows the strain hybridization pattern for
every P. falciparum isolate for the 23,653 SFPs.
Found at DOI: 10.1371/journal.ppat.0020057.st002 (3.2 MB TXT).
Table S3. SFP Data by Gene
This tab-separated text ﬁle shows SFP data compiled by gene.
Found at DOI: 10.1371/journal.ppat.0020057.st003 (257 KB TXT).
Table S4. Polymorphism Variation across the P. falciparum Strains
Analyzed
Found at DOI: 10.1371/journal.ppat.0020057.st004 (55 KB PDF).
Table S5. The Number of Polymorphic Probes per Cluster of Genes
Expressed at Each Stage of the P. falciparum Life Cycle
Clusters 1–15, along with representative genes for each cluster, are
further described in Le Roch et al. [14]. Essentially, genes were
grouped into clusters, based on the expression correlation through-
out the P. falciparum life cycle, by a robust k-means program. While
many of the genes belonging to each cluster encode proteins with
unknown function, those genes with deﬁned cellular roles permitted
a life-cycle stage to be attributed to each of the 15 clusters deﬁned.
Virtually all known sporozoite-speciﬁc genes, such as the CS protein,
reside within cluster 1, and most genes that have known roles in
invasion, such as the MSPs, are found in cluster 15, validating the
cluster assignments.
Found at DOI: 10.1371/journal.ppat.0020057.st005 (57 KB PDF).
Table S6. Highly Variable, Uncharacterized Genes (n ¼ 168)
Genes that are likely to be deleted are underlined.
Found at DOI: 10.1371/journal.ppat.0020057.st006 (73 KB PDF).
Table S7. A List of the Highly Variable, Annotated Genes Observed in
the Laboratory Strains (n ¼ 34)
Aside from those deleted genes (underlined), no distinct differences
were observed between the classes of highly variable genes within the
laboratory strains compared to the Senegal strains (Table 5). Indeed,
no signiﬁcant differences were observed in the variation within
immunogens (p ¼ 0.87) and protein biosynthesis (p ¼ 0.45) genes
between the two groups of isolates, but variation in multi-gene
families was signiﬁcant (p ¼ 6.37E 58).
Found at DOI: 10.1371/journal.ppat.0020057.st007 (66 KB PDF).
Table S8. A List of the Highly Variable, Annotated Genes in the P.
falciparum Strains from Senegal (n ¼ 25)
The notably higher variation observed in the Senegal strains at the
glycophorin-binding protein–related antigen (PF14_0010) locus is
due to a deletion of this gene (underlined) in strain 51.02.
Found at DOI: 10.1371/journal.ppat.0020057.st008 (64 KB PDF).
Table S9. Variation in Characterized Parasite Immunogens in Clinical
Development
Candidate parasite immunogens were derived from Richie and Saul
[2].
Found at DOI: 10.1371/journal.ppat.0020057.st009 (56 KB PDF).
Table S10. Predicted Copy Number for Ampliﬁed Genes
The log2 (Ratio) and copy number, for all P. falciparum Strains, of the
GTP-Cyclohydrolase I (PFL1155w), the two ﬂanking genes (PFL1150c
and PFL1160w), as well as an uncharacterized control gene
(PFL0650c), also located on Chromosome 12. The ratio and copy
number of the P. falciparum multidrug-resistance protein, pfmdr1
(PFE1150w) and the P. falciparum 11-1 protein (PF10_0374) are also
represented. A ratio histogram of the log2 (ratio) for the HB3/3D7
signal intensity (Figure S1) veriﬁes the thresholds used to identify
gene ampliﬁcations. The GTP-cyclohydrolase copy numbers were
extrapolated based on three copies in 3D7, and gene pf11-1 was
extrapolated based on two copies.
Found at DOI: 10.1371/journal.ppat.0020057.st010 (56 KB PDF).
Table S11. Threshold Cycle Values Derived from the Real-Time PCR
Ampliﬁcation of the P. falciparum Genes (PFL1155w, PFL1145w,
PFL1150c, and PFE1150w), along with a b-Tubulin Control Gene
(PF10_0084)
A parallel reaction was carried out for each primer pair, and the
mean threshold cycle (Ct) value and standard deviation are presented.
Found at DOI: 10.1371/journal.ppat.0020057.st011 (58 KB PDF).
Table S12. Gene Deletions Results of the MOID Analysis Showing
Genes Detected as ‘‘Present’’
Found at DOI: 10.1371/journal.ppat.0020057.st012 (8.9 MB XLS).
Table S13. Description of the Genes Deleted in the P. falciparum
Strains Analyzed; Deletions Are Reported Only for Genes with   Six
Probes
No deletions in strain D6 were observed.
Found at DOI: 10.1371/journal.ppat.0020057.st013 (75 KB PDF).
Table S14. Oligonucleotide Primer Sequences
Found at DOI: 10.1371/journal.ppat.0020057.st014 (54 KB PDF).
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